These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2581197)

  • 61. Occupational exposure to hexachlorocyclohexane. III neurophysiological findings and neuromuscular function in chronically exposed workers.
    Baumann K; Behling K; Brassow HL; Stapel K
    Int Arch Occup Environ Health; 1981; 48(2):165-72. PubMed ID: 6167523
    [No Abstract]   [Full Text] [Related]  

  • 62. Invited commentary: interpreting associations between exposure biomarkers and pregnancy outcome.
    Savitz DA
    Am J Epidemiol; 2014 Mar; 179(5):545-7. PubMed ID: 24401560
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Neurological effects of organophosphate pesticides.
    Leon-S FE; Pradilla G; Vesga E
    BMJ; 1996 Sep; 313(7058):690-1. PubMed ID: 8811779
    [No Abstract]   [Full Text] [Related]  

  • 64. Chlordecone intoxication in man. I. Clinical observations.
    Taylor JR; Selhorst JB; Houff SA; Martinez AJ
    Neurology; 1978 Jul; 28(7):626-30. PubMed ID: 79155
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Drug- and Toxin-Induced Opsoclonus - a Systematized Review, including a Case Report on Amantadine-Induced Opsoclonus in Multiple System Atrophy.
    Cannilla H; Messe M; Girardin F; Borruat FX; Bally JF
    Tremor Other Hyperkinet Mov (N Y); 2024; 14():23. PubMed ID: 38737300
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Public health and chronic low chlordecone exposure in Guadeloupe, Part 1: hazards, exposure-response functions, and exposures.
    Nedellec V; Rabl A; Dab W
    Environ Health; 2016 Jul; 15(1):75. PubMed ID: 27406382
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neurological manifestations in humans exposed to chlordecone and follow-up results.
    Taylor JR
    Neurotoxicology; 1982 Oct; 3(2):9-16. PubMed ID: 6186968
    [TBL] [Abstract][Full Text] [Related]  

  • 68. New approaches for treatment of humans exposed to a slowly excreted environmental chemical (chlordecone).
    Guzelian PS
    Z Gastroenterol; 1984 Jan; 22(1):16-20. PubMed ID: 6199909
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The basal ganglia in chlordecone-induced neurotoxicity in the mouse.
    Benet H; Fujimori K; Ho IK
    Neurotoxicology; 1985; 6(1):151-8. PubMed ID: 2581191
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Clinical epidemiology of occupational neurotoxic disease.
    Landrigan PJ; Kreiss K; Xintaras C; Feldman RG; Heath CW
    Neurobehav Toxicol; 1980; 2(1):43-8. PubMed ID: 6160406
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neurological manifestations in humans exposed to chlordecone: follow-up results.
    Taylor JR
    Neurotoxicology; 1985; 6(1):231-6. PubMed ID: 2581197
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Therapeutic approaches for chlordecone poisoning in humans.
    Guzelian PS
    J Toxicol Environ Health; 1981; 8(5-6):757-66. PubMed ID: 6175768
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Chlordecone neurotoxicity: a brief overview.
    Tilson HA; Mactutus CF
    Neurotoxicology; 1982 Oct; 3(2):1-8. PubMed ID: 6186953
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Environmental chemicals and nervous system dysfunction.
    Damstra T
    Yale J Biol Med; 1978; 51(4):457-68. PubMed ID: 87062
    [TBL] [Abstract][Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.